Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer
2018-01-01 Arbour Kathryn, C.; Mezquita, Laura; Long, Niamh; Rizvi, Hira; Auclin, Edouard; Ni, Andy; Martínez-Bernal, Gala; Ferrara, R; Lai W., Victoria; Hendriks Lizza, E. L.; Sabari Joshua, K.; Caramella, Caroline; Plodkowski Andrew, J.; Halpenny, Darragh; Chaft Jamie, E.; Planchard, David; Riely Gregory, J.; Besse, Benjamin; Hellmann Matthew, D.
The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma
2019-01-01 Proto, Claudia; Signorelli, Diego; Mallone, Sandra; Prelaj, Arsela; Lo Russo, Giuseppe; Imbimbo, Martina; Galli, Giulia; Ferrara, R; Ganzinelli, Monica; Leuzzi, Giovanni; Greco Francesca, Gabriella; Calareso, Giuseppina; Botta, Laura; Gatta, Gemma; Garassino, Marina; Trama, Annalisa
Adenosine Pathway in NSCLC With Molecular Drivers: Can Oncogene Addiction Translate Into Immune Addiction?
2022-01-01 Ferrara, R; Milani, Matteo; Garassino Marina, Chiara; Colombo Mario, Paolo; Sangaletti, Sabina
Coronavirus (COVID-19) pandemic mediated changing trends in nuclear medicine education and training: time to change and scintillate
2022-01-01 Gnanasegaran, G.; Paez, D.; Sathekge, M.; Giammarile, F.; Fanti, S.; Chiti, A.; Bom, H.; Vinjamuri, S.; Pascual, T. N.; Bomanji, J.
Hyperprogressive disease: recognizing a novel pattern to improve patient management
2018-01-01 Champiat, Stéphane; Ferrara, R; Massard, Christophe; Besse, Benjamin; Marabelle, Aurélien; Soria, Jean-Charles; Ferté, Charles
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer
2020-01-01 Ferrara, R; Imbimbo, Martina; Malouf, Reem; Paget-Bailly, Sophie; Calais, François; Marchal, Corynne; Westeel, Virginie
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers
2020-01-01 Lobefaro, Riccardo; Viscardi, Giuseppe; Di Liello, Raimondo; Massa, Giacomo; Iacovino Maria, Lucia; Sparano, Francesca; Della Corte Carminia, Maria; Ferrara, R; Signorelli, Diego; Proto, Claudia; Prelaj, Arsela; Galli, Giulia; De Toma, Alessandro; Brambilla, Marta; Ganzinelli, Monica; Trevisan, Benedetta; Ciardiello, Fortunato; De Braud, Filippo; Morgillo, Floriana; Garassino Marina, Chiara; Lo Russo, Giuseppe
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
2019-01-01 Proto, C.; Ferrara, R; Signorelli, D.; Lo Russo, G.; Galli, G.; Imbimbo, M.; Prelaj, A.; Zilembo, N.; Ganzinelli, M.; Pallavicini, L. M.; De Simone, I.; Colombo, M. P.; Sica, A.; Torri, V.; Garassino, M. C.
Atypical patterns of response and progression in the era of immunotherapy combinations
2020-01-01 Ferrara, R; Matos, Ignacio
The Anti–Programmed Cell Death Protein-1/ Programmed Death-Ligand 1 Me-Too Drugs Tsunami: Hard To Be Millennials Among Baby Boomers
2023-01-01 Ferrara, R.; Ricciuti, B.; Ambrogio, C.; Trapani, D.
New technologies—the best is yet to come
2021-01-01 Pini, C.; Chiti, A.
“Slurs and thick terms: When language encodes values”
2023-01-01 Cepollaro, Bianca
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis
2021-01-01 Passiglia, Francesco; Cinquini, Michela; Bertolaccini, Luca; Del Re, Marzia; Facchinetti, Francesco; Ferrara, R; Franchina, Tindara; Larici Anna, R.; Malapelle, Umberto; Menis, Jessica; Passaro, Antonio; Pilotto, Sara; Ramella, Sara; Rossi, Giulio; Trisolini, Rocco; Novello, Silvia
Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients
2019-01-01 Nichetti, Federico; Ligorio, Francesca; Zattarin, Emma; Signorelli, Diego; Prelaj, Arsela; Proto, Claudia; Galli, Giulia; Marra, Antonio; Apollonio, Giulia; Porcu, Luca; de Braud, Filippo; Lo Russo, Giuseppe; Ferrara, R; Garassino Marina, Chiara
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
2019-01-01 Passiglia, F.; Pilotto, S.; Facchinetti, F.; Bertolaccini, L.; Del Re, M.; Ferrara, R; Franchina, T.; Malapelle, U.; Menis, J.; Passaro, A.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S.
Myeloid cell heterogeneity in lung cancer: implication for immunotherapy
2021-01-01 Sangaletti, Sabina; Ferrara, R; Tripodo, Claudio; Garassino Marina, Chiara; Colombo Mario, Paolo
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report
2015-01-01 C, Ciccarese; Ferrara, R; E, Fantinel; C, Zecchetto; F, Simionato; E, Grego; S, Ortolani; M, Caccese; D, Bimbatti; S, Cingarlini; M, Brunelli; A, Andreini; G, Tortora; F, Massari
Circulating innate immune markers and outcomes in treatment-naïve advanced non-small cell lung cancer patients
2019-01-01 Charrier, M.; Mezquita, L.; Lueza, B.; Dupraz, L.; Planchard, D.; Remon, J.; Caramella, C.; Cassard, L.; Boselli, L.; Reiners, K. S.; Pogge von Strandmann, E.; Rusakiewicz, S.; Ferrara, R; Duchemann, B.; Naigeon, M.; Pignon, J. P.; Besse, B.; Chaput, N.
Do immune checkpoint inhibitors need new studies methodology?
2018-01-01 Ferrara, R; Pilotto, Sara; Caccese, Mario; Grizzi, Giulia; Sperduti, Isabella; Giannarelli, Diana; Milella, Michele; Besse, Benjamin; Tortora, Giampaolo; Bria, Emilio
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program
2021-01-01 Prelaj, Arsela; Bottiglieri, Achille; Proto, Claudia; Lo Russo, Giuseppe; Signorelli, Diego; Ferrara, R; Galli, Giulia; De Toma, Alessandro; Viscardi, Giuseppe; Brambilla, Marta; Lobefaro, Riccardo; Nichetti, Federico; Manglaviti, Sara; Occhipinti, Mario; Labianca, Alice; Ganzinelli, Monica; Gallucci, Rosaria; Zilembo, Nicoletta; Greco Gabriella, Francesca; Torri, Valter; de Braud, Filippo; Garassino Marina, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer | 1-gen-2018 | Arbour Kathryn, C.; Mezquita, Laura; Long, Niamh; Rizvi, Hira; Auclin, Edouard; Ni, Andy; Martínez-Bernal, Gala; Ferrara, R; Lai W., Victoria; Hendriks Lizza, E. L.; Sabari Joshua, K.; Caramella, Caroline; Plodkowski Andrew, J.; Halpenny, Darragh; Chaft Jamie, E.; Planchard, David; Riely Gregory, J.; Besse, Benjamin; Hellmann Matthew, D. | |
| The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma | 1-gen-2019 | Proto, Claudia; Signorelli, Diego; Mallone, Sandra; Prelaj, Arsela; Lo Russo, Giuseppe; Imbimbo, Martina; Galli, Giulia; Ferrara, R; Ganzinelli, Monica; Leuzzi, Giovanni; Greco Francesca, Gabriella; Calareso, Giuseppina; Botta, Laura; Gatta, Gemma; Garassino, Marina; Trama, Annalisa | |
| Adenosine Pathway in NSCLC With Molecular Drivers: Can Oncogene Addiction Translate Into Immune Addiction? | 1-gen-2022 | Ferrara, R; Milani, Matteo; Garassino Marina, Chiara; Colombo Mario, Paolo; Sangaletti, Sabina | |
| Coronavirus (COVID-19) pandemic mediated changing trends in nuclear medicine education and training: time to change and scintillate | 1-gen-2022 | Gnanasegaran, G.; Paez, D.; Sathekge, M.; Giammarile, F.; Fanti, S.; Chiti, A.; Bom, H.; Vinjamuri, S.; Pascual, T. N.; Bomanji, J. | |
| Hyperprogressive disease: recognizing a novel pattern to improve patient management | 1-gen-2018 | Champiat, Stéphane; Ferrara, R; Massard, Christophe; Besse, Benjamin; Marabelle, Aurélien; Soria, Jean-Charles; Ferté, Charles | |
| Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer | 1-gen-2020 | Ferrara, R; Imbimbo, Martina; Malouf, Reem; Paget-Bailly, Sophie; Calais, François; Marchal, Corynne; Westeel, Virginie | |
| Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers | 1-gen-2020 | Lobefaro, Riccardo; Viscardi, Giuseppe; Di Liello, Raimondo; Massa, Giacomo; Iacovino Maria, Lucia; Sparano, Francesca; Della Corte Carminia, Maria; Ferrara, R; Signorelli, Diego; Proto, Claudia; Prelaj, Arsela; Galli, Giulia; De Toma, Alessandro; Brambilla, Marta; Ganzinelli, Monica; Trevisan, Benedetta; Ciardiello, Fortunato; De Braud, Filippo; Morgillo, Floriana; Garassino Marina, Chiara; Lo Russo, Giuseppe | |
| Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out | 1-gen-2019 | Proto, C.; Ferrara, R; Signorelli, D.; Lo Russo, G.; Galli, G.; Imbimbo, M.; Prelaj, A.; Zilembo, N.; Ganzinelli, M.; Pallavicini, L. M.; De Simone, I.; Colombo, M. P.; Sica, A.; Torri, V.; Garassino, M. C. | |
| Atypical patterns of response and progression in the era of immunotherapy combinations | 1-gen-2020 | Ferrara, R; Matos, Ignacio | |
| The Anti–Programmed Cell Death Protein-1/ Programmed Death-Ligand 1 Me-Too Drugs Tsunami: Hard To Be Millennials Among Baby Boomers | 1-gen-2023 | Ferrara, R.; Ricciuti, B.; Ambrogio, C.; Trapani, D. | |
| New technologies—the best is yet to come | 1-gen-2021 | Pini, C.; Chiti, A. | |
| “Slurs and thick terms: When language encodes values” | 1-gen-2023 | Cepollaro, Bianca | |
| Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis | 1-gen-2021 | Passiglia, Francesco; Cinquini, Michela; Bertolaccini, Luca; Del Re, Marzia; Facchinetti, Francesco; Ferrara, R; Franchina, Tindara; Larici Anna, R.; Malapelle, Umberto; Menis, Jessica; Passaro, Antonio; Pilotto, Sara; Ramella, Sara; Rossi, Giulio; Trisolini, Rocco; Novello, Silvia | |
| Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients | 1-gen-2019 | Nichetti, Federico; Ligorio, Francesca; Zattarin, Emma; Signorelli, Diego; Prelaj, Arsela; Proto, Claudia; Galli, Giulia; Marra, Antonio; Apollonio, Giulia; Porcu, Luca; de Braud, Filippo; Lo Russo, Giuseppe; Ferrara, R; Garassino Marina, Chiara | |
| Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines | 1-gen-2019 | Passiglia, F.; Pilotto, S.; Facchinetti, F.; Bertolaccini, L.; Del Re, M.; Ferrara, R; Franchina, T.; Malapelle, U.; Menis, J.; Passaro, A.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S. | |
| Myeloid cell heterogeneity in lung cancer: implication for immunotherapy | 1-gen-2021 | Sangaletti, Sabina; Ferrara, R; Tripodo, Claudio; Garassino Marina, Chiara; Colombo Mario, Paolo | |
| Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report | 1-gen-2015 | C, Ciccarese; Ferrara, R; E, Fantinel; C, Zecchetto; F, Simionato; E, Grego; S, Ortolani; M, Caccese; D, Bimbatti; S, Cingarlini; M, Brunelli; A, Andreini; G, Tortora; F, Massari | |
| Circulating innate immune markers and outcomes in treatment-naïve advanced non-small cell lung cancer patients | 1-gen-2019 | Charrier, M.; Mezquita, L.; Lueza, B.; Dupraz, L.; Planchard, D.; Remon, J.; Caramella, C.; Cassard, L.; Boselli, L.; Reiners, K. S.; Pogge von Strandmann, E.; Rusakiewicz, S.; Ferrara, R; Duchemann, B.; Naigeon, M.; Pignon, J. P.; Besse, B.; Chaput, N. | |
| Do immune checkpoint inhibitors need new studies methodology? | 1-gen-2018 | Ferrara, R; Pilotto, Sara; Caccese, Mario; Grizzi, Giulia; Sperduti, Isabella; Giannarelli, Diana; Milella, Michele; Besse, Benjamin; Tortora, Giampaolo; Bria, Emilio | |
| Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program | 1-gen-2021 | Prelaj, Arsela; Bottiglieri, Achille; Proto, Claudia; Lo Russo, Giuseppe; Signorelli, Diego; Ferrara, R; Galli, Giulia; De Toma, Alessandro; Viscardi, Giuseppe; Brambilla, Marta; Lobefaro, Riccardo; Nichetti, Federico; Manglaviti, Sara; Occhipinti, Mario; Labianca, Alice; Ganzinelli, Monica; Gallucci, Rosaria; Zilembo, Nicoletta; Greco Gabriella, Francesca; Torri, Valter; de Braud, Filippo; Garassino Marina, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1052
Data di pubblicazione
- In corso di stampa1
- 2020 - 2025644
- 2010 - 2019335
- 2000 - 200940
- 1990 - 199928
- 1985 - 19894
Editore
- MDPI43
- Elsevier B.V.31
- Frontiers Media S.A.30
- MDPI AG30
- Springer26
- Elsevier Inc.21
- Springer Science and Business Med...21
- W.B. Saunders21
- Elsevier Ltd20
- Lippincott Williams and Wilkins18
Rivista
- CANCERS22
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...21
- JOURNAL OF CARDIOTHORACIC AND VAS...15
- OTORINOLARINGOLOGIA13
- CANCER TREATMENT REVIEWS11
- FRONTIERS IN IMMUNOLOGY11
- CRITICAL REVIEWS IN ONCOLOGY HEMA...10
- INTERNATIONAL JOURNAL OF MOLECULA...9
- JOURNAL OF THORACIC ONCOLOGY9
- ACTA OTORHINOLARYNGOLOGICA ITALICA8
Keyword
- Humans184
- Animals50
- Male35
- COVID-1932
- Female25
- Treatment Outcome23
- SARS-CoV-220
- Adult18
- Biomarkers15
- Transplantation14
Lingua
- eng981
- ita52
- fre2
- spa1
Accesso al fulltext
- no fulltext828
- reserved136
- open87
- partially open1